Sun group reported that SETD2 loss did not affect Wnt/β-catenin signaling in pancreatic ductal adenocarcinoma cells in the context of KrasG12D9 (Niu et al., 2020). This evidence concerns the gene SETD2 and pancreatic ductal adenocarcinoma.